Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis*
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Diabetes patients have an increased risk of sepsis. Several inflammatory and coagulant pathways that are activated during sepsis are also up-regulated in diabetes patients. We tested our a priori hypothesis that the presence of diabetes adversely affects the outcome of sepsis. DESIGN: Retrospective analysis of a previously published study. SETTING: Intensive care units of 164 centers in 11 countries. PATIENTS: Eight hundred thirty severe sepsis patients who were admitted to the intensive care unit and who received standard critical care treatment. INTERVENTIONS: Patients were stratified into diabetic and nondiabetic patient groups. Mortality was assessed after 28 and 90 days, causative microorganisms were evaluated, and markers of coagulation, fibrinolysis, and inflammation were measured at several time points. MEASUREMENTS AND MAIN RESULTS: Diabetes was present in 22.7% of all sepsis patients. Throughout the study, plasma glucose levels were higher in diabetic patients. Mortality was equal in diabetic and nondiabetic patients (31.4% vs. 30.5% after 28 days). Markers of coagulation, fibrinolysis, and inflammation were generally equal in diabetic and nondiabetic patients, although on admission diabetic patients had slightly higher levels of anticoagulation markers. Interestingly, nondiabetic patients with admission hyperglycemia (>11.1 mmol/L; 200 mg/dL) had a higher mortality rate compared to those without admission hyperglycemia (43.0% vs. 27.2%). CONCLUSIONS: Although diabetes is a risk factor for sepsis, once established, the outcome of severe sepsis does not appear to be significantly influenced by the presence of diabetes. In nondiabetic patients, however, admission hyperglycemia is associated with an increased mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 2×
“Importantly, however, two recent trials using intensive insulin treatment in sepsis (33) and critically ill patients (34), respectively, were halted because of an increase in the rate of hypoglycemia without a benefit in terms of mortality.”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566 · cited 1×
“Whereas markers of inflammation, coagulation, and fibrinolysis were reported to be modestly, if at all, elevated in diabetic patients compared to healthy controls (10, 11, 24, 25), they were profoundly increased in septic patients (26, 27).”
Result
Cited by
Krinsley, J. S., Egi, M., Kiss, A., Devendra, A. N., Schuetz, P., Maurer, P. M., Schultz, M. J., van Hooijdonk, R. T., Kiyoshi, M., Mackenzie, I. M., et al. (2013) · Critical Care · doi:10.1186/cc12547 · Cited by 369
Self-citationDiabetes and Infection: Is There a Link? - A Mini-Review
Knapp, S. (2013) · Gerontology · doi:10.1159/000345107 · Cited by 345
van Vught, L. A., Wiewel, M. A., Klein Klouwenberg, P. M. C., Hoogendijk, A. J., Scicluna, B. P., Ong, D. S. Y., Cremer, O. L., Horn, J., Bonten, M. M. J., Schultz, M. J., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001650 · Cited by 130
Abu-Ashour, W., Twells, L., Valcour, J., Randell, A., Donnan, J., Howse, P., & Gamble, J.-M. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000336 · Cited by 113
Inpatient HbA1c testing: a prospective observational study
Nanayakkara, N., Nguyen, H., Churilov, L., Kong, A., Pang, N., Hart, G. K., Owen-Jones, E., White, J., Ross, J., Stevenson, V., et al. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000113 · Cited by 43
Metadata
- Authors
- Stegenga, M. E., Vincent, J.-L., Vail, G. M., Xie, J., Haney, D. J., Williams, M. D., Bernard, G. R., & van der Poll, T.
- Venue
- Critical Care Medicine
- Published
- 2010-02
- Volume
- 38
- Issue
- 2
- Pages
- 539-545
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2077200944
- Cited by
- 131
- References
- 6
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis*. https://app.cochat.ai/papers/10.1097/ccm.0b013e3181c02726
- The paper
- Stegenga, M. E., Vincent, J.-L., Vail, G. M., Xie, J., Haney, D. J., Williams, M. D., Bernard, G. R., & van der Poll, T. (2010). Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis*. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e3181c02726
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.